Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of GLYC will decline by -20.14% over the next 2 Weeks and hit $12.54 by Wednesday, July 16, 2025. In that time frame, GLYC's share price is expected to range between $10.79 and $14.31.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 16, 2025 | 9.71 | 11.66 | 13.52 |
| Jul 15, 2025 | 10.45 | 12.21 | 13.95 |
| Jul 14, 2025 | 9.97 | 11.87 | 13.67 |
| Jul 11, 2025 | 10.29 | 12.24 | 13.99 |
| Jul 10, 2025 | 10.99 | 12.74 | 14.58 |
| Jul 9, 2025 | 11.16 | 13.11 | 15.00 |
| Jul 8, 2025 | 11.84 | 13.65 | 15.52 |
| Jul 7, 2025 | 11.51 | 13.31 | 15.28 |
| Jul 4, 2025 | 11.77 | 13.69 | 15.58 |
| Jul 3, 2025 | 12.36 | 14.19 | 16.03 |
GLYC shares fell -2.76% in Wednesday, July 2, 2025's trading session, dropping from a previous close of $16.15 to move at $15.71. The stock demonstrated notable intraday movement (see GLYC's key stats for a full breakdown), fluctuating between $15.52 and $17.39, a +12.08% trading range. While recent weeks have seen some volatility, GLYC has managed to secure a +0.03% gain over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 106.46K shares changing hands, 39.83K more than the previous session. This amounted to $1.67M in total market activity.
Will GLYC Continue Its Downward Trend?
According to analyst ratings and projections for GLYC, GlycoMimetics, Inc. shares are anticipated to decrease by -16.14%, potentially reaching $13.52 per share by July 16, 2025. Short-term technical indicators currently suggest a neutral sentiment for GLYC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 9 positive trading days within the past 30 sessions. Based on the GLYC stock forecast, now is not the best time to buy GLYC stock because its current trading price is +34.71% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on GLYC covering social and institutional perspectives.
GLYC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into GLYC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 39.49% to 41.18%) suggest mixed signals, with the stock in a neutral to slightly bearish momentum phase. The 50-day RSI, at 42.87%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 44.16%, maintains a neutral outlook for the long term. Insights into GLYC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
GlycoMimetics, Inc. Monthly Forecast 2025–2026
July 2025
According to our latest forecast models, GlycoMimetics, Inc. (GLYC) is positioned to show a strong performance in July 2025. The price is predicted to move between $13.83 and $111.25, settling at an average of $69.63. This could translate to a +343.36% gain.
August 2025
Based on current market signals, GlycoMimetics, Inc. is projected to trend august 2025. We forecast a trading range from $0.00 to $76.28, with a likely average price of $24.74. Investors could expect a potential return of +57.53%.
September 2025
Our predictive algorithms indicate GlycoMimetics, Inc. stock may see a shift in September 2025. The expected range spans $0.00–$87.20, with an average target of $32.72. This represents a positive outlook and a possible gain of +108.34%.
October 2025
Analyzing established trends, GlycoMimetics, Inc. looks set to move in October 2025. Projections place the stock between $0.00 and $91.42, averaging around $46.30. This suggests a +194.81% gain from current levels.
November 2025
Market indicators suggest GlycoMimetics, Inc. could experience notable changes during November 2025. Prices could fluctuate within $0.00 to $95.55, with a midpoint forecast of $53.13. The stock might deliver a +238.30% gain.
December 2025
Forecasting for December 2025, models estimate that GlycoMimetics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $101.81, averaging $51.27. This signals a positive trajectory with potential returns around +226.46%.
January 2026
According to our latest forecast models, GlycoMimetics, Inc. (GLYC) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.00 and $52.54, settling at an average of $8.54. This could translate to a -45.62% loss.
February 2026
Based on current market signals, GlycoMimetics, Inc. is projected to trend february 2026. We forecast a trading range from $0.00 to $70.58, with a likely average price of $18.33. Investors could expect a potential return of +16.71%.
March 2026
Our predictive algorithms indicate GlycoMimetics, Inc. stock may see a shift in March 2026. The expected range spans $0.00–$75.00, with an average target of $31.79. This represents a positive outlook and a possible gain of +102.42%.
April 2026
Analyzing established trends, GlycoMimetics, Inc. looks set to move in April 2026. Projections place the stock between $0.00 and $77.57, averaging around $38.20. This suggests a +143.23% gain from current levels.
May 2026
Market indicators suggest GlycoMimetics, Inc. could experience notable changes during May 2026. Prices could fluctuate within $0.00 to $85.32, with a midpoint forecast of $35.72. The stock might deliver a +127.44% gain.
June 2026
Forecasting for June 2026, models estimate that GlycoMimetics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $39.09, averaging $0.08. This signals a cautious trajectory with potential returns around -99.49%.
July 2026
According to our latest forecast models, GlycoMimetics, Inc. (GLYC) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $25.48, settling at an average of $0.00. This could translate to a -100.00% loss.
GLYC's history of dividends and stock splits also plays a role in long-term investor confidence.

